STOCK TITAN

Davion Healthcare chair gifts 1.6M ordinary shares

Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Davion Healthcare plc (DAVI) executive chairman and director Jack Harry Kaye made four bona fide gifts totaling 1,600,000 ordinary shares to four individuals on November 19, 2026, without consideration. Kaye retained no voting or dispositive power over the gifted shares. After the gifts, he beneficially owned 8,668,948 ordinary shares, approximately 34.68% of the 25,000,000 shares outstanding, with sole voting and dispositive power over those shares.

Ordinary shares gifted 1,600,000 shares Aggregate of four gifts on November 19, 2026
Shares per gift 500,000 shares each Two of the four gifts
Shares per gift 300,000 shares each Two of the four gifts
Pre-gift beneficial ownership 10,268,948 shares Immediately before the gifts
Post-gift beneficial ownership 8,668,948 shares Following the gifts; sole voting and dispositive power
Ownership of ordinary shares outstanding Approximately 34.68% Following the gifts as of November 19, 2026
Ordinary shares outstanding 25,000,000 shares As of November 19, 2026
bona fide gifts regulatory
"four bona fide gifts of ordinary shares"
beneficially owned regulatory
"beneficially owned 8,668,948 ordinary shares"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
Sole Voting Power regulatory
"Sole Voting Power 8,668,948.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Sole Dispositive Power regulatory
"Sole Dispositive Power 8,668,948.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ordinary shares did Jack Kaye give away in the DAVI amendment?

Jack Kaye gave away 1,600,000 ordinary shares in four gifts to four individuals on November 19, 2026. The gifts comprised two transfers of 500,000 shares each and two of 300,000 shares each, without consideration.

How many DAVI shares did Jack Kaye own after the gifts?

After the gifts, Kaye beneficially owned 8,668,948 ordinary shares, approximately 34.68% of the 25,000,000 ordinary shares outstanding.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





G2779R101

(CUSIP Number)
Jack Kaye C/o
MC2 Penrose Wharf, Penrose Quay
Cork, L2, T23 XN53
353 238 808 958

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
11/19/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D




Comment for Type of Reporting Person:
This Amendment No. 2 amends and supplements the Schedule 13D previously filed by Jack Kaye (the "Reporting Person") in respect of the ordinary shares of Davion Healthcare Plc (the "Issuer"). This Amendment is being filed to report four bona fide gifts of ordinary shares made on November 19, 2026, resulting in an aggregate reduction of 1,600,000 ordinary shares in the Reporting Person's beneficial ownership. Except as specifically amended herein, the disclosures contained in the Schedule 13D, as previously amended, remain unchanged.


SCHEDULE 13D


JACK HARRY KAYE
Signature:/s/ Jack Harry Kaye
Name/Title:Jack Kaye, Reporting Person
Date:11/20/2026

Keep reading